Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The amount set forth in rows 5, 7 and 9 above consists of (i) 7,396,213 shares of Common Stock, par value $0.0001 per share (the "Common Stock"), held in estate planning trusts and which the Reporting Person may be deemed to have voting and dispositive power with respect to the shares held by such trusts and (ii) 169,021 shares of Common Stock which the Reporting Person has acquired or has the right to acquire through settlement of restricted stock units within 60 days of September 30, 2025. (2) The percentage of class set forth in row 11 above was calculated based on (i) 168,903,616 shares of Common Stock outstanding as of October 31, 2025, as reported by Astera Labs, Inc. (the "Issuer") in its Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on November 5, 2025 and (ii) 169,021 shares of Common Stock which the Reporting Person has acquired or has the right to acquire through settlement of restricted stock units within 60 days of September 30, 2025 and are deemed outstanding pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended.


SCHEDULE 13G



 
Gajendra Sanjay
 
Signature:/s/ Sanjay Gajendra
Name/Title:Sanjay Gajendra
Date:11/14/2025